Physician

Abhay Agarwal, MD

According to 2025 Medicare claims, Abhay Agarwal, MD (NPI: 1770672057) practices internal medicine in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is CARY MEDICAL CLINIC, PC (NPI: 1184751372; TIN: 270982613) and primary practice location at 27560-8139. Agarwal is affiliated with the Aledade A4548 NC Legacy MSSP Enhanced (ACO ID: A4548), participating under the MSSP model.

Agarwal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 66 traditional Medicare patients, billed 481 HCPCS/CPT codes, and received $19,445 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,275 prescription claims across 134 beneficiaries totaling $148,728 in drug costs, led by Janumet (Sitagliptin Phos/Metformin Hcl). DME data shows 11 claims. Open Payments data shows 31 records totaling $689. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $12,933 to $19,445. Similarly, Part D prescription costs have moved sharply higher in recent years, from $84,294 to $148,728. In contrast, DME billing represents a smaller volume and rose steadily, from $488 to $3,249.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	42	326	$12,933
2016	50	294	$13,159
2017	51	228	$11,841
2018	51	281	$12,680
2019	55	235	$12,495
2020	49	283	$13,199
2021	45	298	$15,738
2022	49	386	$19,588
2023	47	317	$16,900
2024	66	481	$19,445

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	98	1,121	$84,294
2016	103	1,374	$88,224
2017	97	1,251	$69,172
2018	89	1,130	$59,173
2019	86	1,047	$51,711
2020	83	963	$67,584
2021	99	1,155	$119,270
2022	114	1,176	$119,818
2023	140	1,432	$193,599
2024	134	1,275	$148,728

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	19	$406
2016	N/R	16	$272
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	24	$1,607
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	11	$364

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	43	91	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	37	53	$53
G0446	Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes	28	28	$23
G0442	Annual alcohol misuse screening, 5 to 15 minutes	30	30	$17
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	48	86	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Janumet	Sitagliptin Phos/Metformin Hcl	17	1,530	$28,948
Farxiga	Dapagliflozin Propanediol	14	1,020	$18,534
Atorvastatin Calcium	Atorvastatin Calcium	97	8,730	$1,555
Rosuvastatin Calcium	Rosuvastatin Calcium	72	6,480	$1,209
Levothyroxine Sodium	Levothyroxine Sodium	101	9,055	$1,003

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	11	$364

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$689	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abhay Agarwal, MD?

Tedicare shows public-source Medicare data for Abhay Agarwal, MD (NPI 1770672057), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abhay Agarwal, MD have ACO affiliation data?

Abhay Agarwal, MD is shown with ACO affiliation data for Aledade A4548 NC Legacy MSSP Enhanced (MSSP, ACO ID A4548).

What billing organization is linked to Abhay Agarwal, MD?

Abhay Agarwal, MD is linked to CARY MEDICAL CLINIC, PC (billing NPI 1184751372) in the available physician profile data.

Does Abhay Agarwal, MD have Open Payments data?

Abhay Agarwal, MD has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.